Skip to main content
2023 ACCP Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Clinical Drug Development & Investigations

Symposium 10: First-in-Patient Dose Prediction for Adeno-associated Virus-mediated Gene Therapy

4 - Clinical Pharmacology Considerations for Recombinant Adeno-associated, Virus-based Gene Therapy: Focus on Biodistribution, Immune Response & Durability

Tuesday, September 12, 2023
8:00 AM - 11:30 AM PT
Disclosure(s):
Kefeng Sun, PhD: Takeda Pharmaceuticals: Employment (), Owner/Co-Owner Founder/Co-Founder (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) ()